JPH0248567A - 新規ストロンチウム塩 - Google Patents

新規ストロンチウム塩

Info

Publication number
JPH0248567A
JPH0248567A JP1168247A JP16824789A JPH0248567A JP H0248567 A JPH0248567 A JP H0248567A JP 1168247 A JP1168247 A JP 1168247A JP 16824789 A JP16824789 A JP 16824789A JP H0248567 A JPH0248567 A JP H0248567A
Authority
JP
Japan
Prior art keywords
formula
salt
dystrontium
acid
carboxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1168247A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0587064B2 (enExample
Inventor
Michel Wierzbicki
ミシェル　ウイエルズビッキ
Jacqueline Bonnet
ジャックリーヌ　ボネ
Yannis Tsouderos
ヤニ　ツオウデロ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Servier de Medecine Translationnelle SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of JPH0248567A publication Critical patent/JPH0248567A/ja
Publication of JPH0587064B2 publication Critical patent/JPH0587064B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
JP1168247A 1988-06-29 1989-06-29 新規ストロンチウム塩 Granted JPH0248567A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8808729A FR2633619B1 (fr) 1988-06-29 1988-06-29 Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR8808729 1988-06-29

Publications (2)

Publication Number Publication Date
JPH0248567A true JPH0248567A (ja) 1990-02-19
JPH0587064B2 JPH0587064B2 (enExample) 1993-12-15

Family

ID=9367847

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1168247A Granted JPH0248567A (ja) 1988-06-29 1989-06-29 新規ストロンチウム塩

Country Status (16)

Country Link
US (1) US4939164A (enExample)
EP (1) EP0349432B1 (enExample)
JP (1) JPH0248567A (enExample)
AT (1) ATE81118T1 (enExample)
AU (1) AU613297B2 (enExample)
CA (1) CA1312333C (enExample)
DE (1) DE68903059T2 (enExample)
DK (1) DK325289A (enExample)
ES (1) ES2044170T3 (enExample)
FR (1) FR2633619B1 (enExample)
GR (1) GR3006674T3 (enExample)
IE (1) IE64112B1 (enExample)
NZ (1) NZ229760A (enExample)
OA (1) OA09121A (enExample)
PT (1) PT91006B (enExample)
ZA (1) ZA894945B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008523087A (ja) * 2004-12-07 2008-07-03 アボット・ラボラトリーズ バニロイド受容体サブタイプ１（ｖｒ１）を抑制するチエノピリジル化合物およびこの使用
US10183308B2 (en) 2014-10-14 2019-01-22 Conopco, Inc. Spraying device
US10385560B2 (en) 2014-10-14 2019-08-20 Conopco, Inc. Device for spraying an enclosure triggered by inclination of a rotatable lid

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
PT1534305E (pt) * 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
PT1622630E (pt) * 2003-05-07 2012-10-11 Osteologix As Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
US20080167513A1 (en) * 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
DK1768748T4 (da) 2004-06-25 2019-06-11 Mokwalo Spf S A Sammensætninger omfattende strontium og vitamin D og anvendelser deraf
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2954384A (en) * 1960-09-27 Method for preparing kainic acid and its
DE3127275A1 (de) * 1980-12-11 1983-01-27 Leskovar, Peter, Dr.-Ing., 8000 München "harnsteinaufloesende mittel"

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008523087A (ja) * 2004-12-07 2008-07-03 アボット・ラボラトリーズ バニロイド受容体サブタイプ１（ｖｒ１）を抑制するチエノピリジル化合物およびこの使用
US10183308B2 (en) 2014-10-14 2019-01-22 Conopco, Inc. Spraying device
US10385560B2 (en) 2014-10-14 2019-08-20 Conopco, Inc. Device for spraying an enclosure triggered by inclination of a rotatable lid

Also Published As

Publication number Publication date
IE64112B1 (en) 1995-07-12
ATE81118T1 (de) 1992-10-15
FR2633619B1 (fr) 1991-02-08
CA1312333C (fr) 1993-01-05
PT91006A (pt) 1989-12-29
GR3006674T3 (enExample) 1993-06-30
IE892094L (en) 1989-12-29
AU3709289A (en) 1990-01-04
PT91006B (pt) 1994-11-30
NZ229760A (en) 1991-06-25
DK325289D0 (da) 1989-06-29
JPH0587064B2 (enExample) 1993-12-15
ES2044170T3 (es) 1994-01-01
DE68903059T2 (de) 1993-04-29
ZA894945B (en) 1990-03-28
EP0349432A1 (fr) 1990-01-03
FR2633619A1 (fr) 1990-01-05
DK325289A (da) 1989-12-30
US4939164A (en) 1990-07-03
OA09121A (fr) 1991-10-31
DE68903059D1 (de) 1992-11-05
AU613297B2 (en) 1991-07-25
EP0349432B1 (fr) 1992-09-30

Similar Documents

Publication Publication Date Title
US5128367A (en) Divalent metal salts of 2-[N-N-di(carboxymethyl)amino]-3-cyano-4-carboxymethylthiophene-5-carboxylic acid
CN101402565B (zh) 卤代2－（a－羟基戊基）苯甲酸盐及其制法和用途
JPS5838421B2 (ja) 分岐鎖状ケト酸のオルニチン及びアルギニン塩並びに肝臓及び腎臓障害の治療への使用
CA1341114C (en) Pharmaceutical formulations containing melphalan hydrochloride
JPS5843996A (ja) 安定なｓ−アデノシルメチオニン塩、それらの製造法及び活性成分としてこれらを含む治療組成物
HK1042483B (zh) 四氫噻唑的製造方法
JPH0587064B2 (enExample)
FI63568B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara i 7-staellning substituerade 8-aminometylisoflavonderivat
JPS588044A (ja) １１−デオキソグリチルレチン酸水素マレ−ト及びそれを有効成分とする医薬
US4298609A (en) 4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol and salts, their preparation and use as blood pressure lowering agents
CN1128999A (zh) 杂环化合物
WO2012129942A1 (zh) 手性3-羟基吡啶-4-酮类衍生物及其合成和用途
CN105439889B (zh) 一种香兰素胺类新化合物、其制备方法及医药用途
FI92391C (fi) Menetelmä 3-(N-fenyyliasetyyliaminopiperidiini)-2,6-dionin valmistamiseksi
US20100261764A1 (en) Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof
CN110684066B (zh) 胞二磷胆碱药物制剂及其脑梗塞急性期意识障碍的新用途
RU2281085C2 (ru) Антидепрессивные лекарственные средства для парентерального применения на основе сульфонатных солей пирлиндола
RU2045268C1 (ru) Противогистаминное и антиаллергическое средство и способ приготовления глутамината хинуклидил-3-дифенилкарбинола в виде раствора для инъекций
JPS5910563A (ja) α−（Ｎ−ピロリル）−フエニル酢酸誘導体およびその製造方法
CN119241400B (zh) 一种脒基磺酰胺衍生物及其应用
CN117105857B (zh) 一种米力农-肉桂酸晶体以及制备方法
JPS6026386B2 (ja) 新規イソインド−ル化合物
FR2624120A1 (fr) Nouveaux sels organogermaniques utiles comme medicaments notamment comme activateurs des osteoblastes
RU2448967C2 (ru) Соли производных пирролопиримидинона и способ их получения
CN101805337B (zh) 一类含脯氨酸和异恶唑骨架的化合物、其制备方法和用途